Rick Wise
Stock Analyst at Stifel
(3.99)
# 468
Out of 5,182 analysts
272
Total ratings
57.27%
Success rate
8.4%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $110 → $105 | $82.90 | +26.66% | 17 | Apr 29, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $85 | $56.50 | +50.44% | 20 | Apr 21, 2026 | |
| ABT Abbott Laboratories | Maintains: Buy | $145 → $120 | $89.46 | +34.14% | 22 | Apr 17, 2026 | |
| JNJ Johnson & Johnson | Maintains: Hold | $220 → $250 | $227.19 | +10.04% | 9 | Apr 15, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $98 | $61.03 | +60.58% | 4 | Feb 5, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $105 → $110 | $83.98 | +30.98% | 29 | Jan 20, 2026 | |
| MDLN Medline | Initiates: Buy | $46 | $44.75 | +2.79% | 1 | Jan 12, 2026 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $5 → $3 | $1.86 | +61.29% | 10 | Jan 7, 2026 | |
| SOLV Solventum | Maintains: Buy | $88 → $105 | $66.63 | +57.59% | 2 | Jan 7, 2026 | |
| OM Outset Medical | Maintains: Buy | $14 → $8 | $4.36 | +83.49% | 6 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $70 | $61.00 | +14.75% | 7 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $210 → $215 | $149.31 | +44.00% | 9 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $28.67 | +39.52% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $15.63 | +27.96% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $105 | $80.00 | +31.25% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $36.21 | +27.04% | 8 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $36 → $25 | $17.21 | +45.26% | 9 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $5 | $1.35 | +270.37% | 5 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $55 | $36.80 | +49.46% | 12 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $21.82 | +28.32% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $29.02 | +65.40% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $294.73 | +49.29% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $457.78 | +33.25% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $178.48 | +6.45% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $6.86 | +74.93% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $112.04 | -33.06% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $19.42 | +23.58% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $24.66 | +1.38% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $69.24 | +61.76% | 5 | Oct 2, 2020 |
Zimmer Biomet Holdings
Apr 29, 2026
Maintains: Buy
Price Target: $110 → $105
Current: $82.90
Upside: +26.66%
Boston Scientific
Apr 21, 2026
Maintains: Buy
Price Target: $90 → $85
Current: $56.50
Upside: +50.44%
Abbott Laboratories
Apr 17, 2026
Maintains: Buy
Price Target: $145 → $120
Current: $89.46
Upside: +34.14%
Johnson & Johnson
Apr 15, 2026
Maintains: Hold
Price Target: $220 → $250
Current: $227.19
Upside: +10.04%
GE HealthCare Technologies
Feb 5, 2026
Maintains: Buy
Price Target: $95 → $98
Current: $61.03
Upside: +60.58%
Edwards Lifesciences
Jan 20, 2026
Maintains: Buy
Price Target: $105 → $110
Current: $83.98
Upside: +30.98%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $46
Current: $44.75
Upside: +2.79%
Treace Medical Concepts
Jan 7, 2026
Maintains: Hold
Price Target: $5 → $3
Current: $1.86
Upside: +61.29%
Solventum
Jan 7, 2026
Maintains: Buy
Price Target: $88 → $105
Current: $66.63
Upside: +57.59%
Outset Medical
Jan 7, 2026
Maintains: Buy
Price Target: $14 → $8
Current: $4.36
Upside: +83.49%
Jan 7, 2026
Maintains: Buy
Price Target: $65 → $70
Current: $61.00
Upside: +14.75%
Jan 7, 2026
Maintains: Buy
Price Target: $210 → $215
Current: $149.31
Upside: +44.00%
Nov 13, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $28.67
Upside: +39.52%
Oct 10, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $15.63
Upside: +27.96%
Oct 9, 2025
Maintains: Hold
Price Target: $90 → $105
Current: $80.00
Upside: +31.25%
Sep 29, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $36.21
Upside: +27.04%
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $17.21
Upside: +45.26%
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.35
Upside: +270.37%
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $36.80
Upside: +49.46%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $21.82
Upside: +28.32%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $29.02
Upside: +65.40%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $294.73
Upside: +49.29%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $457.78
Upside: +33.25%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $178.48
Upside: +6.45%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $6.86
Upside: +74.93%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $112.04
Upside: -33.06%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $19.42
Upside: +23.58%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $24.66
Upside: +1.38%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $69.24
Upside: +61.76%